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Abstract
Background: Sexually transmitted diseases (STD) are frequently asymptomatic and increase the likelihood of
transmitting and acquiring HIV. In Brazil, the guidelines for STDs diagnosis and treatment are based on the
syndromic approach. Nucleic acid amplification tests (NAAT) has been recommended as routine STDs screening in
some countries, especially for men who have sex with men (MSM). Limited data are available about how to best define
target groups for routine screening by NAATs within this population. We aimed to assess the prevalence of rectal and
urethral Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections and syphilis, and the factors associated
with having at least one STD among HIV-infected and uninfected MSM in Rio de Janeiro, Brazil.
Methods: From August 2010 to June 2012, 391 MSM were enrolled into the Evandro Chagas National Institute of
Infectious Diseases-INI-Fiocruz cohort, and 292 MSM (HIV-infected:211 and HIV-uninfected:81) were included in
this study. NAATs were performed on the rectal swabs and urine for CT and NG. The rapid plasma reagin test and
microhemagglutination assay for Treponema pallidum were performed for syphilis diagnosis.
Results: The overall prevalence of STD was 20.0 % (95%CI:15.7-25.1): 10 % anorectal chlamydia; syphilis 9.9 %;
anorectal gonorrheae 2.5 %; and urethral chlamydia 2.2 %; no case of urethral gonorrheae was detected. The
proportion of HIV-positive MSM who had at least one STD was nearly two times that of HIV-negative MSM
(22.6 % vs 13.2 %; P = 0.09). The frequency of each STD, except for anorectal NG (1.5 % vs.5.2 %), was higher among
HIV-positive than HIV-negative individuals. Among the 211 asymptomatic participants, 17.5 % (n = 37) were identified as
having at least one STD; 10.4 % (n = 22/211) tested positive for anorectal chlamydia. Sixty five percent of HIV-positive
MSM were asymptomatic at the time of the STD diagnosis, while 100.0 % of the HIV-negative MSM. Age (APR = 0.78;
95%CI:0.60-1.00 for each additional ten years) and a positive-HIV serostatus (APR = 2.05; 95%CI:1.03-4.08) were significantly
associated with STD diagnosis.
Conclusion: An overall high STD-prevalence rate was observed, especially among HIV-infected and in younger
individuals, and the majority of STDs were asymptomatic. STD screening using NAATs among asymptomatic MSM
is a potentially cost-effective intervention for the prevention of HIV infection among MSM.
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Background
In developed settings, the prevalence of sexually trans-
mitted diseases (STDs) among gay and other men who
have sex with men (MSM) has been on an upward trend
since the late 1990s [1]. In low- and middle-income
countries STDs are a significant burden to the health
care system [2], further fueled by a lack of systematic
surveillance and population-based studies of STD preva-
lence. In South America, including Brazil, the proportion
of new HIV infections is on the rise in young gay and
other MSM [3], making this population particularly vul-
nerable to other sexually transmitted diseases (STDs) [4].
There are several factors, such as the number of sexual
partners [5], inconsistent condom use [6] and HIV infec-
tion [7] that are associated with increased prevalence of
STDs among MSM. Individuals infected with HIV are
more susceptible to other STDs because they are im-
munocompromised and less capable of mounting a pro-
tective response against sexually transmitted pathogens
[8, 9]. STDs are frequently asymptomatic, therefore, in-
creasing the likelihood of transmitting and acquiring
HIV [10].
Because targeted groups within this population are not
well defined or studied, routine STD screening should
be recommended for all MSM [11]. In Brazil, STD clinical
management relies mostly on the syndromic approach, as
molecular STD diagnosis is not routinely available in the
Public Health System [12].
This study aimed to assess the prevalence of rectal and
urethral CT and Neisseria gonorrhoeae (NG) infections
and syphilis, as well as to describe the factors associated
with a positive diagnosis of at least one STD among
HIV-infected and uninfected MSM at a referral center
for MSM health in Rio de Janeiro, Brazil.
Materials and Methods
A cross-sectional analysis, nested within a cohort study
was conducted at Evandro Chagas National Institute of
Infectious Diseases-INI-Fiocruz (formerly known as the
Evandro Chagas Clinical Research Institute-IPEC), Rio
de Janeiro, Brazil. The parent cohort study was designed
to evaluate the prevalence and incidence of anal HPV in-
fection and intraepithelial anal lesions among HIV in-
fected and uninfected men [13]. In summary, men were
recruited by trained staff either while in the clinic wait-
ing room or by phone. Inclusion criteria for the parent
cohort study were: being aged 18 years or older, not hav-
ing anal cancer or related treatments (surgery, radiother-
apy, and chemotherapy) and a willingness to sign the
informed consent form. The exclusion criteria were: the
use of immunomodulators agents, such as prednisone
(dosage > 10 mg/day), interleukin or interferon. HIV
positive men were already under care at the INI HIV
Clinic, and HIV negative men attending the clinic for
HIV prevention services. At the enrollment visit, infor-
mation on demographic, sexual behavior, substance use
as well as history of prior STDs were collected using
Audio Computer Assisted Interview (ACASI) and speci-
mens for STD diagnostic testing were collected. The
study population for the present analysis were men who
have sex with men (MSM), herein defined as men that
reported having at least 1 male sexual partner within the
past 12 months (regardless of having female partners).
From August 2, 2010 to June 30, 2012, 391 MSM were
enrolled into the parent cohort study. Of these, 72
(18.4 %) were excluded for not having a male sexual
partner(s) within the last 12 months, and 27 (6.9 %) were
excluded because of missing information regarding their
sexual partners within the past 12 months (Fig. 1). In
total, 292 MSM were included in this analysis. To deter-
mine the prevalence for each specific STD, we consid-
ered all participants who had available results for each of
the STDs under evaluation, thus explaining the different
denominators. The outcome “Having one or more STD
at study entry” was defined as having a positive testing
for at least one of the following STDs: CT (rectal, ureth-
ral, or urine), NG (rectal, urethral, or urine) or syphilis,
at the study baseline visit. If a participant tested positive
for at least one of the STDs under evaluation, regardless
of having missing data on other STD tests, his data con-
tributed to the analysis of the outcome “Having one or
more STD at study entry”. Thus, 275 men were included
in the analysis of the associated factors of having at least
one STD (Fig. 1).
STD diagnosis
Rectal CTand NG infection were diagnosed using APTIMA
Combo 2 assay (Gen-Probe/Hologic San Diego, CA). Test-
ing was processed at the Johns Hopkins STD Laboratory, in
Baltimore, Maryland, USA. All indeterminate results for
rectal CT/NG were repeated using the same tests on the
same sample. If the repeated test was conclusive, the results
were reported accordingly. If remained indeterminate, the
result was reported as negative. Urethral CT and NG infec-
tion were diagnosed using urine samples on the Abbott
RealTime platform and the NG/CT Amplification Reagent
Kit (Abbott Molecular, Des Plains, IL); these samples were
processed at the INI-Fiocruz Laboratories.
The rapid plasma reagin (RPR) test was performed for
syphilis screening; positive results were confirmed using
a microhemagglutination assay for Treponema pallidum
(MHA-TP). Titers equal to or higher than 1/8 and a posi-
tive MHA-TP constituted a syphilis diagnosis. HIV in-
fection was diagnosed according to the Brazilian HIV
diagnosis algorithm (www.aids.gov.br). HIV-negative par-
ticipants were tested at the baseline visit and also at each
follow-up visit. Both the INI-Fiocruz Laboratories and
the Johns Hopkins University STD Research Laboratory
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successfully participate in the College of American Pa-
thologists (CAP) External Quality Assurance (EQA)
proficiency testing panels for all relevant testing associ-
ated with this study.
Measures
STD-related symptoms included urethral/anal discharge,
anal or genital nodules, anal or genital ulcers, spontan-
eous anal pain, tenesmus and anal pruritus. Individuals
were considered symptomatic when at least one of the
above-referenced symptoms was reported.
Demographic variables included age, self-reported skin
color (further classified as white or non-white) and
schooling (years of formal education).
The number of male and female sexual partners
within the last 12 months was determined using the fol-
lowing questions: “During the past 12 months, how
many men and how many transvestite/transsexual/trans-
gender(s) did you have sex with?” and “During the past
12 months, how many women did you have sex with?”
The latter question was categorized as “none” or “at least
one female partner”.
Stable partner in the past 3 months was defined as
“Yes” if the participant considered at least one sexual
partner within the last 3 months to be a stable partner
(husband, wife, boyfriend or girlfriend).
HIV-positive male sexual partner in the past 3 months
was determined using the following questions: a) “In the
past 3 months, how many HIV-positive male partners
did you have insertive anal sex with?” and b) “In the past
3 months, how many HIV- positive male partners did
you have receptive anal sex with?”.
Each study participant provided information, if known,
on the HIV serostatus of his sexual partners. Independ-
ent HIV testing was not performed on the partners.
Alcohol and stimulant use before or during sex were
determined using the following questions: “In the past
3 months, were you drunk or high before or during sex?"
and “In the past 3 months, did you use either inhaled or
intravenous illicit drugs before or during sex?” [14].
Commercial sex within the past 3 months was defined
as the exchange of sex for money/other favors and/or
seeking commercial sex workers. This was determined
using the following questions: “In the past 3 months, did
you have sex for money, drugs or other favors?” and “In the
past 3 months, did you look for commercial sex workers?”.
Anal sexual practices with male partners during the
past 3 months were evaluated using the following ques-
tions: a) “In the past 3 months, how many HIV-negative
male partners did you have insertive anal sex with?”; b)
“In the past 3 months, how many male partners, with an
unknown HIV-serostatus did you have insertive anal sex
with?”; c) “In the past 3 months, how many HIV-
negative male partners did you have receptive anal sex
with?”; and d)“In the past 3 months, how many male
partners, with an unknown HIV-serostatus did you have
receptive anal sex with?” The answers were categorized
as ‘only insertive’, ‘only receptive’ or ‘both’.
Unprotected anal intercourse during the past 3 months
was defined as any positive answer to the following ques-
tions: “In the past 3 months how many: a) HIV-negative
male partners did you have insertive anal sex with, without
using condoms? b) male partners, with an unknown HIV-
serostatus did you have insertive anal sex with, without
using condoms? c) HIV-negative male partners did you
MSM enrolled in IPEC/FIOCRUZ
Men Cohort
HIV + 294 / HIV - 97
Total =391
With male partner in the past
12 months
N=292 (HIV+ 211 / HIV - 81)
MSM who were evaluated for 
STD risk markers
N=275 (HIV+ 199 / HIV - 76)
Missing data in the male partner 
in the past 12 months: N=27
Without male partner in the past 
12 months: N=72
1.Missing data for all STD: N=2
2. Missing data for at least one of the
STDs and who presented negative
results for the others: N=15
Fig. 1 Study population- INI/Fiocruz, 2010–2012
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have receptive anal sex with, without using condoms? and
d) male partners, with an unknown HIV-serostatus, did
you have receptive anal sex with, without using condoms?”.
Statistical analysis
For those with results available we have described the
overall prevalence of CT, NG and syphilis. These results
are sorted out based on HIV status. The overall prevalence
for having one or more STD at study entry’ outcome and
the confidence interval for the proportion [15] were calcu-
lated and are also presented sorted to HIV status using
Chi-square test for comparison. Generalized linear models
using logarithmic linkage and Poisson distribution with
robust variance were used to estimate the prevalence ratio
between selected variables and the outcome [16]. Age,
schooling, skin color, number of male sexual partners
within the previous 12 months, having female partners,
having a stable partner, having an HIV-positive sexual
partner, having been high from alcohol and having used
stimulants before/during sex, reporting commercial sex,
position during anal sex, unprotected anal sex with male
partner (s) in the last 3 months and HIV status were
evaluated in the univariate analysis. Variables that were
associated with an STD according to the univariate analysis
(P < 0.25) were entered into the initial multivariate model.
Multi-colinearity was tested using generalized colinearity
diagnostics (GVIF). Variables were kept in the final multi-
variate model if (a) the P value < 0.05 or (b) it was a con-
founder, e.g., when removed, a change equal or higher than
10 % in the prevalence ratio of any other variable of the
model was observed [17]. We forced the variable age
(a priori) into the multivariate models. The STATA/SE
10.1 software was used to perform the analysis.
Ethics
The study was approved by the IPEC-FIOCRUZ IRB
(CAAE 0044.0.009.000-09); all study participants signed
an informed consent prior to cohort enrollment.
Results
Overall 292 participants were included in this analysis,
211 HIV-infected and 81 HIV-uninfected. The HIV-
infected participants were significantly older than the
HIV-uninfected [median (IQR): 39.0 (31.0–46.0) vs 33.0
(27.0–40.0); P = 0.000], more frequently self-reported as
white (53.4 % vs 27.5 %; P < 0.0001), had a lower number
of male sexual partners within the previous 12 months
[median (IQR): 5.0 (2.0–10.0) vs 10.0 (4.0–20.0); P =
0.002], and had less unprotected receptive or insertive
anal sex with other men during the past 3 months
(35.6 % vs 50.7 %; P = 0.027) Overall, 8.3 % (n = 24/289)
of participants were circumcised (7.5 % HIV-infected
and 8.6 % HIV-uninfected; P = 0.759). The median time
since HIV diagnosis was 75.8 (41.2–162.4) months; 77 %
(n = 161/209) of the HIV-infected participants were using
cART at study entry; the median CD4 cell count (IQR)
was 555.0 (375.0–789.5) cells/mm3 with 7.8 % (n = 15/
192) having less than 200 cells/mm3; 37.1 % (75/202) had
a detectable HIV viral load. All study participants con-
sented to STD screening including the genital swabbing
procedures.
STD prevalence
Table 1 shows the prevalence of STD, both overall and
individual, stratified by HIV status. The most frequently
diagnosed STDs were rectal Chlamydia (10.0 %) and
Syphilis (9.9 %), while urethral Chlamydia (2.2 %) and
Rectal Gonorrhea (2.5 %) were less commonly reported.
Among MSM who participated in the analysis of associ-
ated factors to have at least one STD, 199 and 76 were
HIV-infected and uninfected MSM, respectively. A total
of 20.0 % (95%CI: 15.7–25.1) had at least one STD, not
including HIV infection. The proportion of HIV-positive
MSM who had at least one STD (N = 45/199) was nearly
1.7 times that found for the HIV-negative MSM (N = 10/
76) (22.6 % vs 13.2 % P = 0.09). A single STD was de-
tected in 14.7 % (n = 43) participants and 4.1 % (n = 12)
were diagnosed with two STDs. The frequency of each
Table 1 Prevalence of sexually transmitted diseases among MSM-INI-Fiocruz, Rio de Janeiro, Brazil
Gonorrhea Chlamydia Syphilis At least one STD
Urethral Rectal Urethral Rectal
(N = 273)a (N = 279)a (N = 273)a (N = 279)a (N = 284)a (N = 275)b
N (%) - 7 (2.5) 6 (2.2) 28 (10.0) 28 (9.9) 55 (20.0)
HIV serostatus. N (%)
Positivec - 3 (1.5) 6 (3.0) 24 (11.9) 22 (10.8) 45 (22.6)
Negatived - 4 (5.2) - 4 (5.2) 6 (7.5) 10 (13.2)
aDifferent denominators are explained by availability of results for each STD evaluated
bParticipants who tested positive for at least one STD, regardless of having missing information for other STD, were included and considered as an event. HIV-infected
MSM= 199; HIV-uninfected MSM= 76
cNumber of HIV-infected MSM according to the availability of results for each STD: urethral NG = 197; anorectal NG = 202; urethral CT = 197; anorectal CT = 202;
Syphilis = 204; At least one STD = 199
dNumber of HIV-uninfected MSM according to availability of results for each STD: urethral NG = 76; anorectal NG = 77; urethral CT = 76; anorectal CT = 77; Syphilis = 80;
At least one STD = 76
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STD, except for anorectal NG, was higher among HIV-
positive than HIV-negative individuals.
STD symptoms
Information on STD symptoms was available for 263
participants, with 211 (80.2 %) being asymptomatic and
52 (19.8 %) reported having symptoms (Table 2). Ano-
rectal symptoms were reported by 10.9 % of participants,
with rectal discharge (3.4 %), anal nodules (4.1 %), and
anal ulcers (5.2 %) being the most frequently reported
symptoms. Of the 32 participants with anorectal CT or
NG infection, 9.4 % had anorectal symptoms; 1.5 % and
2.3 % of the participants reported having genital ulcers
or nodules, respectively. No urethral discharge was re-
ported. Among MSM with syphilis, 13 % presented rectal
or genital ulcers.
Among the 211 asymptomatic participants, 17.5 %
(n = 37) were identified as having at least one STD:
rectal gonorrhea in 2.8 %, urethral chlamydia in 1.5 %, rec-
tal chlamydia in 10.4 %, and syphilis in 5.7 %. 65 % of the
HIV-infected MSM and 100 % of the HIV negative MSM
were asymptomatic at the time of the STD diagnosis.
Participants’ characteristics according to STD diagnosis
The characteristics of these participants are described in
Table 3 and are sorted by STD infection status. For
those participants with at least one STD (n = 55), the
median age was 35.0 years (IQR 29.0–42.0); approxi-
mately 20 % had less than eleven years of schooling;
53.7 % self-reported to be non-white. The median num-
ber of male sexual partners in the last 12 months was
8.0 (IQR 3.0–27.0).Within the last 3 months before en-
tering the study, 32.7 % participants had an HIV-positive
partner; 20.8 % used stimulants before or during sex;
46.3 % practiced commercial sex, and almost 60 % re-
ported both insertive and receptive anal sex. Almost half
of the HIV-infected MSM diagnosed with an STD had a
detectable plasma HIV viral load.
Factors associated with STD diagnosis
In the univariate analysis, besides age and HIV serostatus,
some sexual risk behaviors were found to be associated
with high STD prevalence. For each 10 male sexual
partners in the past 12 months, a 1 % increase in STD
prevalence was observed (NAPRs = 1.01; 95 % CI: 1.00–
1.02). MSM who reported having HIV-positive male sex-
ual partners during the 3 months prior to cohort enroll-
ment had a higher STD prevalence as opposed to those
who reported no such partners (NAPRs = 1.46; 95 % CI:
0.88–2.42). Stimulant use before or during sex in the
3 months prior to cohort enrollment (NAPRs = 1.52; 95 %
CI: 0.86–2.70) was also associated to a high STD prevalence
in the univariate analysis.
In the final multivariate model, age (APR = 0.78; 95 %
CI: 0.60-1.00 for each additional ten years) and HIV infec-
tion (APR = 2.05; 95 % CI: 1.03–4.08) remained significantly
associated with any STD diagnosis (Table 4).
Discussion
A high STD prevalence rate was observed among the
MSM enrolled in this study, particularly anorectal CT
(10 %) and syphilis (9.9 %). Because of its potential for
facilitating HIV acquisition and transmission, the high
prevalence of anorectal CT infection may be a contribut-
ing factor to the ongoing HIV epidemic in MSM in our
setting. In order to confirm this hypothesis, additional
representative, population-based MSM studies are needed.
Our findings are consistent with other reports [18],
showing that most anorectal chlamydial and gonoccocal
infections as well as syphilis were asymptomatic. Our data
emphasize the need to educate MSM, particularly those
who are HIV infected, on the topic of STD awareness.
Asymptomatic STDs are especially concerning because as
the untreated infections persist, the risk of contracting
and transmitting HIV increases [19]. Additionally, in the
absence of symptoms, the infected individual is not
prompted to seek health services or adjust his risk prac-
tices [20]. We believe that these data are the first to de-
scribe the prevalence of anorectal CT and NG in MSM in
Brazil. Our findings illustrate the urgent need to imple-
ment STD screening to MSM [11, 21], as they remain the
most affected by the HIV epidemic in our country [3].
As seen in other studies, when compared to HIV-
negative men, HIV-positive men were more often diag-
nosed with STD (22.6 % vs 13.2 %) [22–25]. We observed
that the HIV-infected MSM in our study had a high
prevalence of anorectal CT and syphilis as seen in other
settings [26, 27]. The discrepancy between sexual behavior
and STD prevalence may be explained by the fact that
HIV-positive individuals enrolled in our study were en-
gaged in care and had a median follow-up period of
6.5 years (IQR: 3.4–13.5), therefore receiving positive pre-
vention counselling that might have influenced their sex-
ual risk behavior. Moreover, as STD molecular screening
is not standard of care in Brazil, and diagnosis is only done
using the syndromic approach, it may be the case that the
higher prevalence among the HIV positive MSM was
Table 2 Proportion of at least one STDa among symptomaticb
and asymptomatic MSM, INI/Fiocruz, Rio de Janeiro,Brazil
At least one STD Symptomaticb, n (%) Asymptomatic, n (%)
Yes 15 (28.8) 37 (17.5)
No 37 (71.2) 174 (82.5)
Total 52 (100.0) 211 (100.0)
aAt Least One STD = Chlamydia/Gonoccocal urethral and/or anal infection
or Syphilis
bSyntomatic = report of uretrhal/anal discharge, anal or genital nodule, anal or
genital ulcer, spontaneous anal pain, tenesm and, anal pruritis
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driven by infections acquired prior to their linkage to care,
that may have remained undiagnosed and thus, untreated.
In our study, only two variables were associated with
an increased risk of a STD diagnosis in the multivariate
analysis, younger age and HIV co-infection. Several studies
have also found that younger age is associated with an
increased risk for a STD diagnosis [7, 28, 29]. This finding
is of paramount importance because 40 % of new HIV
diagnoses in Brazil are among the very young MSM
aged 15–24 years [3]. Our study showed that for every
additional ten years of age, the prevalence of having at
least one STD decreased by 22 %. These results may
Table 3 Characteristics of MSM according to sexually transmitted disease. INI/FIOCRUZ, Rio de Janeiro, Brazil
Characteristics Sexually Transmitted Disease – N(%)
No Yes Total
N = 275
Age1 38.0 (30.0-46.0) 35.0 (29.0-42.0) 38.0 (30.0-45.0)
Less than 11 years of schooling 50 (23.1) 12 (22.2) 62 (23.0)
Skin color – Non White 117 (53.7) 29 (53.7) 146 (53.7)
No. of male sexual partners in the last 12 months1 5.0 (2.0-14.0) 8.0 (3.0-27.0) 5.0 (2.0-15.0)
Had a female sexual partner in the last 12 months 23 (10.5) 7 (12.7) 30 (10.9)
Had a stable partner in the last 3 months 100 (46.9) 25 (47.2) 125 (47.0)
HIV-positive male sexual partner in the last 3 months 48 (23.1) 17 (32.7) 65 (25.0)
High from alcohol use before/during sex in the last 3 months 120 (56.3) 29 (54.7) 149 (56.0)
Stimulant use before/during sex in the last 3 months 28 (13.1) 11 (20.8) 39 (14.7)
Commercial sex in the last 3 months 86 (40.4) 25 (46.3) 111 (41.6)
Anal intercourse with men in the last 3 months
Only insertive 34 (16.3) 8 (15.4) 42 (16.2)
Only receptive 43 (20.7) 5 (9.6) 48 (18.5)
Both 101 (48.6) 30 (57.7) 131 (50.4)
None sexual partner 30 (14.4) 9 (17.3) 39 (15.0)
Unprotected anal sex with men in the last 3 months 80 (38.5) 23 (44.2) 103 (39.6)
HIV infected 154 (70.0) 45 (81.8) 199 (72.4)
Time since HIV diagnosis, months (N = 185)
Median (IQR) 75.4 (40.3-163.8) 85.4 (42.0-161.9) 78.5 (41.2-162.4)
<12 6 (4.1) 1 (2.6) 7 (3.8)
12-36 28 (19.2) 8 (20.5) 36 (19.5)
>36 112 (76.7) 30 (76.9) 142 (76.8)
Currently receiving cART (N = 197) 122 (80.3) 33 (73.3) 155 (78.7)
Current CD4 (N = 183)
Median (IQR) 542.0 (359.0-781.0) 597.5 (425.0-803.0) 554.0 (376.0-781.0)
<200 11 (7.7) 3 (7.5) 14 (7.7)
200-350 23 (16.1) 4 (10.0) 27 (14.8)
>350 109 (76.2) 33 (82.5) 142 (77.6)
Total 143 (100.0) 40 (100.0) 183 (100.0)
HIV viral load (N = 193)
Indetectable 99 (65.6) 23 (54.8) 122 (63.2)
Detectable 52 (34.4) 19 (45.2) 71 (36.8)
Total 151 (100.0) 42 (100.0) 193 (100.0)
Missing data: STD = 5.8 %, Years of schooling = 3.1 %, Skin color = 2.1 %, Female sexual partner in the last 12 months = 4.1 %, Stable partner in the last 3 months = 3.4 %,
HIV-positive male sexual partner in the last 3 months = 5.8 %, High from alcohol use before/during sex in the last 3 months = 3.4 %, Stimulant use before or during sex
in the last 3 months = 3.4 %, Commercial sex in the last 3 months = 3.1 %, Anal intercourse with men in the last 3 months = 5.8 %, Unprotected anal sex
with men in the last 3 months = 5.8 %, Time since HIV diagnose = 7.0 %, Currently receiving cART = 1.0 %, Current CD4 = 8.0 %, HIV viral load = 3.0 %.
1Median (IQR)
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contribute to the development of recommendations for
targeted routine STD screenings for MSM in our setting.
Potential explanations for the lack of an association
with well-accepted variables, such as the number of sex-
ual partners, stimulant use before or during sex in the
past 3 months and unprotected sex, are the different
methods and measures used across the different studies
and the limited sample size. Another explanation may be
related to our definition of STD, which combined differ-
ent STDs into a composite endpoint. For example, dif-
ferent factors may be predictive of syphilis, urethral CT
and rectal NG.
Although progress has been made in increasing HIV
prevention and treatment services in resource-limited
settings, major hurdles remain for the diagnosis of other
STDs. As a result the information on CT and GC infec-
tion is likely to be grossly underestimated. Because many
STDs are asymptomatic, the current clinical standard of
relying on sexually active persons to self-detect STD
symptoms is an inadequate triage method [30]. Although
it is well recognized that routine STD testing for MSM
should be incorporated into the Brazilian clinical guidelines,
the high cost burden to implement such testing makes it an
unattainable goal. More epidemiological, coupled with cost
effectiveness studies are urgently needed to better define
targeted MSM groups for screening. Our results show
that younger MSM and those living with HIV/AIDS are
important targets for STD screening. The striking
benefit of cART in preventing HIV transmission among
heterosexual and MSM serodiscordant couples [29, 30]
has paved the way and triggered the expansion of utiliz-
ing cART for prevention. Hence, STD co-infections in
HIV-infected populations may have significant implica-
tions on the expected outcomes of the HIV Test and
Treat policy, which was recently adopted by the Brazilian
Ministry of Health [31].
Our study has several limitations. First, regardless of
HIV serostatus, all participants were under care at our
institution. As a result they may have received HIV pre-
vention counseling and may have received STD treat-
ment, prior to enrollment into the parent cohort study,
leading to an underestimation of our STD prevalence
rate. In addition, although we have used CASI to collect
sexual behavior data, we cannot exclude that underre-
porting of risky sexual risk behavior in HIV-infected
MSM was related to social desirability bias. We enrolled
a convenience sample at a single site, and data may not
be generalizable to MSM in Brazil. In addition, the small
sample size precluded the analysis of factors associated
with individual STDs.
Conclusions
In summary, our findings showing a high STD prevalence
rate, especially the high proportion of asymptomatic GC
and CT infections support the CDC recommendation to
offering periodic CT and GC NAAT testing to MSM in
Table 4 Factors associated with sexually transmitted diseases diagnosis among MSM. INI/FIOCRUZ, Rio de Janeiro, Brazil
Characteristics PRa (CI 95 %)
NAPRb P value APRc P value
Age (each ten years) 0.82 (0.64-1.05) 0.110d 0.78 (0.60-1.00) 0.049
Less than 11 years of schooling 0.96 (0.54-1.71) 0.885 - -
Skin color – Non White 1.00 (0.62-1.62) 0.996 - -
No. of male sexual partners in the last 12 months (each ten partners) 1.01 (1.00-1.02) 0.095d
Had a female sexual partner in the last 12 months 1,19 (0,59-2,39) 0,623 - -
Had a stable partner in the in the last 3 months 1.01 (0.62-1.63) 0.977 - -
HIV-positive male sexual partner in the last 3 months 1.46 (0.88-2.42) 0.146d - -
High from alcohol use before/during sex in the last 3 months 0.95 (0.58-1.54) 0.832 - -
Stimulant use before/during sex in the last 3 months 1.52 (0.86-2.70) 0.148d - -
Commercial sex in the last 3 months 1.21 (0.75-1.95) 0.431 - -
Anal intercourse with men in the last 3 months (Ref: Only insertive)
Only receptive 0.55 (0.19-1.55) 0.255 - -
Both 1.20 (0.60-2.42) 0.606 - -
None sexual partner 1.21 (0.52-2.83) 0.658 - -
Unprotected anal sex with men in the last 3 months 1.21 (0.74-1.97) 0.447 - -
HIV infected 1.72 (0.91-3.24) 0.094d 2.05 (1.03-4.08) 0.040
aPR = Prevalence Ratio
bNAPR = Non-Adjusted Prevalence Ratio
cAPR = Adjusted Prevalence Ratio; 260 participants were included in the multivariate models; 15/275 (5.4 %) had missing data in at least one covariate
d Variables with P < 0.25 in univariate analysis and were entered in the initial multivariate model
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developing countries [11]. It poses a challenge to the
Brazilian health system that offers only syndromic man-
agement of STD irrespective of the population. [32].
Lack of diagnosis of asymptomatic GC and CT infec-
tions in a context of an epidemic mostly driven by
MSM may compromise the impact of the current test–
and-treat strategy on the control of the HIV epidemic
in Brazil. Routine GC and CT NAAT testing targeting
asymptomatic MSM may be proven to be cost-effective
and should be explored in Brazil [33].
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